ResMed (ASX:RMD) Achieves Double-Digit Revenue and Profit Growth in 2QFY25
ResMed Inc. (ASX:RMD) is an ASX-listed company that offers digital health technologies and cloud-connected medical devices. In the quarter ended 31 December 2024 (2QFY25), the company recorded a 10% YoY revenue growth, reaching USD 1,282.1 million, driven by increased demand for sleep and respiratory …
Team Kalkine |
12 Mar 2025| Read Time : 10 Mins